1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer
(
- Contribution to journal › Article
- 2017
-
Mark
M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases
(
- Contribution to journal › Article
- 2016
-
Mark
Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model
(
- Contribution to journal › Article
- 2014
-
Mark
Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
(
- Contribution to journal › Article
- 2013
-
Mark
The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells
(
- Contribution to journal › Article
-
Mark
The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
(
- Contribution to journal › Article
- 2004
-
Mark
Getting supply chain strategies involved in “E-commerce & Environment” - a research potentioal for LCA case studies
2004) 10th World Congress on Transport Research(
- Contribution to conference › Paper, not in proceeding
- 1986
-
Mark
Anionic glycerophospholipids in platelets from alcoholics
(
- Contribution to journal › Article